Immunotherapy Stocks List


Recent Signals

Date Stock Signal Type
2019-04-18 ADAP MACD Bearish Centerline Cross Bearish
2019-04-18 ADAP Stochastic Reached Oversold Weakness
2019-04-18 AIMT New 52 Week Low Weakness
2019-04-18 AIMT Lower Bollinger Band Walk Weakness
2019-04-18 AIMT New 52 Week Closing Low Bearish
2019-04-18 ALPN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 ALPN 20 DMA Support Bullish
2019-04-18 APTO Narrow Range Bar Range Contraction
2019-04-18 ARDS Fell Below 50 DMA Bearish
2019-04-18 ARDS Narrow Range Bar Range Contraction
2019-04-18 ARDS NR7 Range Contraction
2019-04-18 ARGX Lower Bollinger Band Walk Weakness
2019-04-18 BLCM Lower Bollinger Band Walk Weakness
2019-04-18 BLCM MACD Bearish Centerline Cross Bearish
2019-04-18 CDMO Crossed Above 20 DMA Bullish
2019-04-18 CDMO Bollinger Band Squeeze Range Contraction
2019-04-18 CDMOP 50 DMA Support Bullish
2019-04-18 CDMOP 180 Bullish Setup Bullish Swing Setup
2019-04-18 CDMOP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 CDMOP Cup with Handle Other
2019-04-18 CDMOP Stochastic Reached Overbought Strength
2019-04-18 CDMOP 200 DMA Support Bullish
2019-04-18 CDMOP 20 DMA Support Bullish
2019-04-18 CDTX MACD Bearish Centerline Cross Bearish
2019-04-18 CDTX NR7 Range Contraction
2019-04-18 CDTX Narrow Range Bar Range Contraction
2019-04-18 CLBS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-04-18 CLBS Lower Bollinger Band Walk Weakness
2019-04-18 CLBS 1,2,3 Retracement Bearish Bearish Swing Setup
2019-04-18 CLBS NR7 Range Contraction
2019-04-18 CLDX Lower Bollinger Band Walk Weakness
2019-04-18 CLDX New 52 Week Closing Low Bearish
2019-04-18 CLDX Narrow Range Bar Range Contraction
2019-04-18 CLDX New 52 Week Low Weakness
2019-04-18 CVM NR7 Range Contraction
2019-04-18 CVM 180 Bullish Setup Bullish Swing Setup
2019-04-18 DBVT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 DTIL New 52 Week Low Weakness
2019-04-18 DTIL New 52 Week Closing Low Bearish
2019-04-18 DTIL Hot IPO Pullback Bullish Swing Setup
2019-04-18 ENLV New Downtrend Bearish
2019-04-18 FBIO Wide Range Bar Range Expansion
2019-04-18 FBIO Stochastic Buy Signal Bullish
2019-04-18 FBIO 20 DMA Resistance Bearish
2019-04-18 FBIO Gilligan's Island Sell Setup Bearish Swing Setup
2019-04-18 FBIO Pocket Pivot Bullish Swing Setup
2019-04-18 FBIO Slingshot Bearish Bearish Swing Setup
2019-04-18 FBIO 50 DMA Resistance Bearish
2019-04-18 FBIO 200 DMA Resistance Bearish
2019-04-18 FBIO Volume Surge Other
2019-04-18 FBIOP Wide Range Bar Range Expansion
2019-04-18 FBIOP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 FBIOP Pocket Pivot Bullish Swing Setup
2019-04-18 FBIOP Crossed Above 20 DMA Bullish
2019-04-18 FBIOP Crossed Above 50 DMA Bullish
2019-04-18 GNCA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 GNCA 50 DMA Support Bullish
2019-04-18 GRTS Fell Below 20 DMA Bearish
2019-04-18 GRTS NR7 Range Contraction
2019-04-18 GRTS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 HARP 180 Bullish Setup Bullish Swing Setup
2019-04-18 IMRN Narrow Range Bar Range Contraction
2019-04-18 IMRN NR7 Range Contraction
2019-04-18 IMRN Calm After Storm Range Contraction
2019-04-18 IMUX Crossed Above 20 DMA Bullish
2019-04-18 IMUX Calm After Storm Range Contraction
2019-04-18 IMV MACD Bearish Signal Line Cross Bearish
2019-04-18 IMV Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-04-18 IMV 180 Bearish Setup Bearish Swing Setup
2019-04-18 IMV Lower Bollinger Band Walk Weakness
2019-04-18 INMB Narrow Range Bar Range Contraction
2019-04-18 INMB Calm After Storm Range Contraction
2019-04-18 INMB NR7-2 Range Contraction
2019-04-18 INMB NR7 Range Contraction
2019-04-18 IOVA 20 DMA Support Bullish
2019-04-18 IOVA 50 DMA Support Bullish
2019-04-18 IOVA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 JNCE Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 JNCE Doji - Bullish? Reversal
2019-04-18 JNCE 50 DMA Support Bullish
2019-04-18 MBIO New 52 Week High Strength
2019-04-18 MBIO Volume Surge Other
2019-04-18 MBIO Wide Range Bar Range Expansion
2019-04-18 MBIO New Uptrend Bullish
2019-04-18 MBIO Stochastic Buy Signal Bullish
2019-04-18 MBIO Lower Bollinger Band Walk Weakness
2019-04-18 MBIO Slingshot Bearish Bearish Swing Setup
2019-04-18 MBIO Gilligan's Island Sell Setup Bearish Swing Setup
2019-04-18 MBIO Crossed Above 20 DMA Bullish
2019-04-18 MBIO Crossed Above 50 DMA Bullish
2019-04-18 MBIO Crossed Above 200 DMA Bullish
2019-04-18 MBIO Expansion Breakout Bullish Swing Setup
2019-04-18 MBIO MACD Bullish Signal Line Cross Bullish
2019-04-18 MBIO Pocket Pivot Bullish Swing Setup
2019-04-18 MRKR NR7 Range Contraction
2019-04-18 NLNK Stochastic Buy Signal Bullish
2019-04-18 ONCS Fell Below 50 DMA Bearish
2019-04-18 ONCS Calm After Storm Range Contraction
2019-04-18 ONCS 20 DMA Resistance Bearish
2019-04-18 PDSB New 52 Week Closing Low Bearish
2019-04-18 PDSB Stochastic Reached Oversold Weakness
2019-04-18 REPL Lower Bollinger Band Walk Weakness
2019-04-18 REPL Stochastic Buy Signal Bullish
2019-04-18 REPL Crossed Above 50 DMA Bullish
2019-04-18 SBOT 1,2,3 Pullback Bullish Bullish Swing Setup
2019-04-18 SBOT Narrow Range Bar Range Contraction
2019-04-18 SBOT Lower Bollinger Band Walk Weakness
2019-04-18 SELB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-04-18 SELB 50 DMA Support Bullish
2019-04-18 SELB 1,2,3 Pullback Bullish Bullish Swing Setup
2019-04-18 SURF Narrow Range Bar Range Contraction
2019-04-18 SURF Stochastic Buy Signal Bullish
2019-04-18 SURF Spinning Top Other
2019-04-18 SURF NR7 Range Contraction
2019-04-18 TCRR 20 DMA Support Bullish
2019-04-18 TCRR Stochastic Reached Overbought Strength
2019-04-18 UMRX Lower Bollinger Band Walk Weakness
2019-04-18 UMRX NR7 Range Contraction

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy